Global Health Limited , operating under the Medanta brand, has reported robust financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

The company's consolidated total income for Q1 FY2026 reached ₹10,513.00 million, marking a substantial 19.10% year-on-year increase. This growth was primarily driven by higher patient volumes and improved realization.

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) saw an even stronger performance, growing by 22.60% year-on-year to ₹2,553.00 million. The EBITDA margin improved to 24.30%, up from 23.60% in the same quarter last year.

Profit After Tax (PAT) showed remarkable growth, surging by 49.60% to reach ₹1,590.00 million. The PAT margin expanded significantly to 15.10%, compared to 12.00% in Q1 FY2025.

Operational Performance

Global Health's operational metrics also showed positive trends:

• Occupied bed days increased by 13.30%, reflecting an occupancy rate of 63.20% on an expanded bed capacity.
• Average Revenue Per Occupied Bed (ARPOB) grew by 4.00% to ₹66,584.00, driven by increased realization in the Gurugram unit and changes in specialty mix.
• In-patient volumes rose by 14.20%, while out-patient volumes increased by 13.10% year-on-year.

Segment Performance

Mature Hospitals

The company's mature hospitals (over 6 years old) saw revenue growth of 10.70% year-on-year, reaching ₹7,006.00 million. EBITDA for this segment grew by 6.70% to ₹1,640.00 million.

Developing Hospitals

Developing hospitals (less than 6 years old) demonstrated even stronger growth, with revenue surging by 35.90% to ₹3,219.00 million. EBITDA for this segment showed impressive growth of 59.80%, reaching ₹942.00 million.

Expansion and Future Outlook

Global Health continues to focus on expansion and capacity enhancement:

• A newly built 110-bed hospital in Ranchi was operationalized in July 2025.
• The company added 20 new beds at its Patna facility during the quarter.
• Construction of a 550-bed hospital in Noida is progressing, with operations expected to commence with 300 beds in Q2 FY2026.

Management Commentary

Commenting on the results, Mr. Pankaj Sahni, Group CEO and Director, said, "I am pleased to report another strong quarter, delivering our highest ever Total Income and EBITDA with year-on-year growth of 19% and 23% respectively. This robust performance was driven by increased patient volumes and improved realizations, with consistent growth across mature hospitals as well as Lucknow and Patna hospital."

He added, "Backed by a balanced portfolio of assets and a strong balance sheet, we are well-positioned to execute our long-term growth strategy and further expand the Medanta model of care across the region."

Global Health's strong Q1 FY2026 performance underscores its continued growth trajectory and successful expansion strategy in the healthcare sector.

Global Health Limited , the operator of Medanta hospitals, has reported strong financial results for the first quarter of fiscal year 2026, demonstrating significant growth in both revenue and profitability.

Financial Highlights

• Revenue from operations increased by 19.6% year-over-year to ₹10,308.37 crore
• Consolidated net profit jumped 49.6% to ₹1,589.82 crore
• EBITDA rose to ₹2,270.00 crore, up from ₹1,860.00 crore in the same period last year
• EBITDA margin improved to 22.02% from 21.64% year-over-year

The company's robust performance was driven by enhanced operational efficiency alongside revenue growth across its healthcare services.

Operational Performance

Global Health continued to strengthen its position in the healthcare sector during the quarter. The company's focus on delivering high-quality medical services and expanding its reach has contributed to the strong financial results.

Management Commentary

While specific management comments were not provided, the significant improvement in financial metrics suggests that Global Health's strategic initiatives and operational excellence are yielding positive results.

Future Outlook

The company appears well-positioned for continued growth, with plans for expansion and improvement of its healthcare facilities. During the quarter, Global Health received an offer to acquire a land parcel in Guwahati, Assam, for establishing a super specialty hospital, indicating its commitment to expanding its presence in different regions.

Corporate Governance

The Board of Directors has recommended the re-appointment of key personnel, including Dr. Naresh Trehan as Chairman and Managing Director, and Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia as Independent Directors, subject to shareholder approval. These reappointments reflect the company's focus on maintaining strong leadership and corporate governance.

Global Health's impressive Q1 FY2026 results demonstrate its resilience and growth potential in the competitive healthcare sector. With a strong financial foundation and strategic expansion plans, the company is well-equipped to capitalize on the growing demand for quality healthcare services in India.